The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $14.06

Today's change-1.33 -8.64%
Updated November 28 1:00 PM -5GMT. Delayed by at least 15 minutes.
 

Hydrogenics Corp

Nasdaq: HYGS
Last

(U.S.) $14.06

Today's change-1.33 -8.64%
Updated November 28 1:00 PM -5GMT. Delayed by at least 15 minutes.

Hydrogenics Corp down (U.S.)$1.33

Hydrogenics Corp closed sharply lower Friday, dropping (U.S.)$1.33 or 8.64% to (U.S.)$14.06. Over the last five days, shares have lost 12.89% and sit 2.63% above their 52-week low. This security has underperformed the S&P 500 by 20.67% during the last year.

Key company metrics

  • Open(U.S.) $15.12
  • Previous close(U.S.) $15.39
  • High(U.S.) $15.12
  • Low(U.S.) $14.01
  • Bid / Ask-- / --
  • YTD % change-26.58%
  • Volume103,154
  • Average volume (10-day)116,409
  • Average volume (1-month)152,365
  • Average volume (3-month)133,607
  • 52-week range(U.S.) $13.70 to (U.S.) $35.52
  • Beta0.11
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.86
Updated November 28 1:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-20.15%

Hydrogenics Corp has a net profit margin of -20.15%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1111811
Total other revenue--------
Total revenue1111811
Gross profit3323
Total cost of revenue8768
Total operating expense12101213
Selling / general / administrative3255
Research & development1110
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total------0
Operating income-10-4-2
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-4-3
Income after tax-10-4-3
Income tax, total0000
Net income-10-4-3
Total adjustments to net income--------
Net income before extra. items-10-4-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-4-3
Inc. avail. to common incl. extra. items-10-4-3
Diluted net income-10-4-3
Dilution adjustment0000
Diluted weighted average shares101099
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.01-0.41-0.34
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.13-0.01-0.41-0.34